Affiliation:
1. Hamad General Hospital, Hamad Medical Corporation
2. Hamad Medical Corporation
3. Weill Cornell Medical College
Abstract
Abstract
Primary splenic lymphoma represents a rare lymphoproliferative disorder that involves the spleen, exhibiting diverse clinical presentations and lacking a clear consensus in terms of management strategies. We present the case of a 52-year-old patient with a complex medical history, marked by multiple chronic medical conditions. The patient was diagnosed with primary splenic lymphoma, specifically the diffuse large B-cell subtype. Treatment for our patient involved a shortened course of chemotherapy (4 cycles of R-CHOP followed by two doses of rituximab) due to issues related to compliance and treatment-related complications. This was followed by consolidative radiotherapy, without resorting to splenectomy. Remarkably, the patient achieved complete resolution, and a positron emission tomography (PET) scan conducted at the end of the 6-month post-treatment period confirmed sustained complete remission.
Publisher
Research Square Platform LLC
Reference24 articles.
1. Primary malignant lymphomas of the spleen. A morphologic and immunohistochemical analysis of 17 cases;Falk S;Cancer,1990
2. Non-Hodgkin's lymphoproliferative disorders involving the spleen;Arber DA;Mod pathology: official J United States Can Acad Pathol Inc,1997
3. Splenectomy in lymphoproliferative disorders: a report on 70 cases and review of the literature;Coad JE;Leuk Lymphoma,1993
4. Splenomegaly in 2,505 patients in a large university medical center from 1913 to 1995. 1913 to 1962: 2,056 patients;O'Reilly RA;Western J Med,1998
5. Azar RK, Al-Hawary S, M. M., Francis IR (2010) Primary and secondary neoplasms of the spleen. Cancer imaging: the official publication of the International Cancer Imaging Society, 10(1), 173–182. https://doi.org/10.1102/1470-7330.2010.0026